southern
africa
remark
rich
plant
divers
approxim
flower
plant
speci
equat
nearli
higher
plant
global
van
wyk
plant
use
medicin
centuri
medicin
plant
trade
still
promin
today
accord
world
health
organ
peopl
live
african
contin
equat
half
billion
peopl
use
tradit
medicin
meet
primari
health
care
need
nonetheless
industri
yet
exploit
full
capac
south
africa
exampl
around
medicin
plant
speci
frequent
use
plantbas
medicin
howev
less
indigen
speci
commerci
degre
van
wyk
statist
hiv
southern
african
region
emphas
devast
effect
million
peopl
live
hiv
worldwid
million
peopl
becam
newli
infect
hiv
unaid
subsaharan
africa
account
peopl
newli
infect
hiv
peopl
live
hiv
unaid
collect
eastern
southern
africa
home
global
popul
account
peopl
live
hiv
nearli
half
approxim
million
peopl
becam
infect
hiv
unaid
antiretrovir
therapi
art
effect
treatment
peopl
live
hiv
standard
treatment
seek
suppress
hiv
replic
cycl
halt
diseas
progress
antiretrovir
therapi
signific
improv
life
peopl
live
hiv
howev
drug
mani
disadvantag
includ
resist
toxic
limit
avail
lack
cur
effect
chinsembu
hedimbi
potenti
hiv
becom
resist
antiretrovir
arv
treatment
becom
increas
concern
sinc
first
report
decad
ago
de
clercq
pathogen
becom
drug
resist
need
develop
new
medicin
realiz
world
shortcom
open
avenu
use
natur
product
manag
hivaid
electron
search
scienc
direct
pubm
central
googl
scholar
undertaken
search
term
hiv
medicin
plant
africa
antivir
southern
africa
initi
public
titl
screen
suitabl
plant
speci
activ
compound
mode
action
document
primari
literatur
sourc
ethnobotan
survey
african
countri
ethiopia
asr
et
al
uganda
lamord
et
al
cameroon
mbaveng
et
al
zimbabw
viol
et
al
namibia
chinsembu
hedimbi
zambia
chinsembu
also
assist
identifi
plant
tradit
use
manag
hiv
hiv
symptom
inclus
criteria
plant
record
traditionalpopular
use
infecti
viral
diseas
hiv
treatment
symptom
similar
hiv
infect
traditionallypopularli
use
plant
close
relat
plant
popular
use
hiv
activ
identifi
mean
vitro
assay
plant
identifi
scientif
nativ
southern
african
region
antihiv
activ
within
accept
rang
clinic
relev
concentr
defin
ic
extract
individu
compound
appli
select
criterion
studi
agarw
et
al
butterweck
nahrstedt
co
et
al
gertsch
sinc
tradit
refer
plant
long
histori
use
hiv
rel
new
diseas
use
plant
refer
popular
popularli
use
hiv
mani
plant
tradit
use
treat
viral
infect
ailment
investig
claim
led
discoveri
numer
plant
deriv
antihiv
compound
wide
distribut
natur
singh
et
al
therefor
screen
medicin
plant
provid
opportun
discoveri
hiv
inhibitor
lower
toxic
andor
side
effect
narayan
et
al
biolog
activ
substanc
harvest
plant
found
organ
plant
although
leaf
materi
tradit
use
narayan
et
al
variou
laboratori
base
investig
conduct
use
plant
extract
isol
compound
employ
varieti
assay
test
perform
enzym
revers
transcriptas
rt
integras
proteas
pr
protein
involv
activ
viral
gene
cell
infect
virus
pseudovirus
activ
determin
indic
mtt
luciferas
activ
mtt
assay
base
reduct
yellow
colour
bromid
mtt
mitochondri
dehydrogenas
metabol
activ
cell
metabol
activ
cell
blue
formazan
produc
measur
spectrophotometr
indic
cell
viabil
assay
cell
prolifer
cytotox
co
et
al
shoemak
et
al
target
aim
determin
inhibit
reduct
viral
infect
variou
level
present
variou
advantag
disadvantag
consid
evalu
antivir
activ
tabl
rt
convert
viral
rna
genom
viral
dna
use
polymeras
domain
rna
depend
dna
polymeras
activ
ribonucleas
h
rnase
h
domain
degrad
rna
compon
intermediari
rnadna
complex
enzym
also
dnadepend
dna
polymeras
function
clinic
avail
rt
drug
therefor
target
enzym
numer
studi
focus
rt
enzym
variou
protocol
employ
measur
thymidin
triphosph
ttp
rt
use
polyadenyl
acidoligodeoxythymidil
acid
polyaoligodt
templat
primer
presenc
absenc
test
substanc
isol
compound
plant
extract
ali
et
al
bessong
et
al
variou
kit
use
determin
inhibit
enzym
viral
compon
captur
elisa
kit
genxbio
health
scienc
india
chinnaiyan
et
al
hivrt
colourimetr
enzymelinkedimmunosorb
serolog
assay
elisa
kit
obtain
roch
diagnost
mannheim
germani
chukwujekwu
et
al
eldeen
et
al
kapewangolo
et
al
klo
et
al
tshikalang
et
al
wang
et
al
purifi
recombin
rt
enzym
merck
darmstadt
germani
kapewangolo
et
al
sever
interact
measur
identifi
optimis
assay
condit
found
rt
use
magnesium
manganes
dival
ion
cofactor
bolton
et
al
palladium
iron
might
also
affect
assay
respons
irrevers
inhibit
rt
subsequ
reduct
viru
prolifer
filler
lever
sinc
ion
variou
metal
accumul
plant
therefor
present
plant
extract
ion
may
present
might
affect
outcom
methodolog
describ
inhibit
rt
crude
plant
extract
take
consider
effect
metal
ion
regul
activ
rt
bessong
obi
consequ
would
import
determin
metal
ion
plant
extract
prior
screen
order
avoid
fals
inhibitori
observ
screen
stage
conjunct
accessori
viral
protein
requir
integr
synthes
viral
doubl
strand
dna
chromosom
nucleu
host
cell
integras
enzym
also
employ
extract
compound
catechin
variou
studi
use
xpress
assay
kit
express
biotech
intern
usa
vitro
model
jiang
et
al
recombin
e
coli
origin
wang
et
al
evalu
process
activ
perform
extract
compound
bessong
et
al
unspecif
bind
plant
compound
protein
howev
mostli
consid
pr
cleav
viral
polyprotein
structur
function
compon
assembl
form
progeni
virion
bessong
obi
proteas
enzym
also
investig
variou
assay
fluorometr
detect
hivpr
activ
use
hivii
pr
hivfret
fluoresc
reson
energi
transfer
anaspec
inc
usa
recombin
proteas
solut
bachem
tabl
summari
popular
antihiv
assay
present
advantag
disadvantag
assay
bessong
obi
bolton
et
al
chukwujekwu
et
al
collin
et
al
eldeen
et
al
filler
lever
kapewangolo
et
al
klo
et
al
tshikalang
et
al
wang
et
al
integras
enzym
requir
integr
synthes
viral
doubl
strand
dna
chromosom
nucleu
xpress
assay
kit
acquir
variou
compani
fals
posit
obtain
due
unspecif
bind
plant
compound
protein
bessong
obi
jiang
et
al
klo
et
al
wang
et
al
proteas
pr
assay
proteas
enzym
cleav
viral
polyprotein
structur
function
compon
assembl
form
progeni
virion
assay
kit
hivii
pr
hivfret
fluoresc
reson
energi
transfer
recombin
proteas
solut
acquir
variou
compani
fals
posit
obtain
due
unspecif
bind
plant
compound
protein
bessong
obi
harnett
et
al
jiang
et
al
kapewangolo
et
al
klo
et
al
wang
et
al
assay
enzymelink
immunosorb
assay
use
detect
quantifi
core
protein
inhibit
determin
decreas
viral
antigen
level
measur
absorb
nm
antigen
assay
kit
acquir
variou
compani
fals
posit
obtain
due
unspecif
bind
plant
compound
protein
klo
et
al
cell
base
assay
infect
isol
hiv
strain
pseudovirion
hiv
cell
cultur
maintain
ad
cell
contain
plant
extract
compound
activ
measur
use
mtt
assay
cell
infect
recombin
viru
obtain
transfect
plasmid
contain
luciferas
gene
luciferas
activ
measur
assay
reli
inhibit
singl
enzym
target
test
use
viru
pseudovirion
transfect
constitu
antioxid
activ
result
high
mtt
activ
redoxbas
assay
free
thiol
lead
reduct
mtt
formazon
product
therefor
inaccur
result
obtain
plant
compound
iso
flavonoid
stabil
firefli
luciferas
report
enzym
increas
bioluminesc
signal
probabl
due
direct
interact
compound
firefli
luciferas
report
enzym
therebi
increas
halflif
stabil
enzym
activ
compound
stabil
firefli
luciferas
report
protein
give
fals
posit
auld
et
al
co
et
al
ngwira
et
al
prinsloo
et
al
shoemak
et
al
sotoca
et
al
wang
et
al
activ
assay
cell
stabli
transfect
plasmid
contain
firefli
luciferas
gene
driven
hivltrpromot
highli
depend
activ
induc
high
express
luciferas
activ
reflect
activ
canon
pathway
plantderiv
antivir
compound
interf
ltr
promot
regulatori
protein
unlik
gener
drugresist
hiv
strain
plant
compound
iso
flavonoid
stabil
firefli
luciferas
report
enzym
increas
bioluminesc
signal
probabl
due
direct
interact
compound
firefli
luciferas
report
enzym
therebi
increas
halflif
stabil
enzym
activ
compound
stabil
firefli
luciferas
report
protein
give
fals
posit
auld
et
al
sotoca
et
al
tshikalang
et
al
helatatluc
assay
helatatluc
cell
stabli
transfect
plasmid
togeth
report
plasmid
ltrluc
ltr
highli
activ
cell
line
consequ
high
level
intracellular
tat
protein
ltr
promot
regulatori
protein
unlik
gener
drugresist
hiv
strain
plant
compound
iso
flavonoid
stabil
firefli
luciferas
report
enzym
increas
bioluminesc
signal
probabl
due
direct
interact
compound
firefli
luciferas
report
enzym
therebi
increas
halflif
stabil
enzym
activ
auld
et
al
sotoca
et
al
tshikalang
et
al
helatetonluc
assay
extract
activ
inhibit
tat
inhibit
assay
evalu
helateton
assay
discard
nonspecif
luciferas
inhibitori
activ
ltr
promot
regulatori
protein
unlik
gener
drugresist
hiv
strain
elimin
nonspecif
luciferas
activ
switzerland
glycohydrolas
enzym
found
eukaryot
host
cell
golgi
apparatu
respons
glycosyl
protein
inhibit
glycohydrolas
enzym
decreas
infect
hiv
virion
hiv
envelop
protein
highli
glycosyl
life
cycl
viru
glucosidas
found
partli
respons
glycosyl
hiv
harnett
et
al
kapewangolo
et
al
klo
et
al
escherichia
coli
express
recombin
pr
also
use
detect
inhibitori
effect
sampl
pr
observ
bacteri
growth
curv
jiang
et
al
wang
et
al
elisa
kit
anoth
enzymelink
immunosorb
assay
also
avail
detect
quantifi
core
protein
use
antigen
assay
kit
beckman
coulter
miami
fl
usa
klo
et
al
distinguish
cell
base
assay
cell
base
assay
commonli
use
variou
differ
cell
type
virus
wildtyp
refer
virus
louvel
et
al
bind
entri
assay
pbmc
describ
letean
et
al
utilis
format
ifig
infect
format
fusioninduc
gene
stimul
repres
vitro
infect
system
human
hela
cell
therebi
upon
infect
hiv
report
gene
induc
quantifi
fashion
beta
galactosidas
allow
quantif
inhibitori
effect
compound
extract
lubb
et
al
pseudovirion
virus
use
ngwira
et
al
prinsloo
et
al
wang
et
al
helatatluc
cell
stabli
transfect
instanc
plasmid
togeth
report
plasmid
ltrluc
indic
protein
activ
therefor
ltr
highli
activ
cell
line
consequ
high
level
intracellular
tat
protein
tshikalang
et
al
isol
hiv
strain
strain
htlviiiblai
obtain
cultur
supernat
hivinfect
cell
line
test
cell
viabil
evalu
use
mtt
assay
co
et
al
african
green
monkey
kidney
cell
vero
also
use
dang
et
al
link
cytotox
assay
cell
maregesi
et
al
maregesi
et
al
even
though
mtt
assay
gener
appli
determin
cell
viabil
vitro
assay
littl
consider
given
possibl
constitu
antioxid
potenti
result
extrem
high
mtt
read
might
provid
fals
posit
result
stabil
luciferas
gene
also
often
consid
even
though
mani
plant
compon
might
provid
fals
posit
result
auld
et
al
sotoca
et
al
cytotox
extract
compound
often
also
neglect
therefor
select
index
si
achiev
divid
cytotox
concentr
cc
effect
inhibitori
concentr
ec
therapeut
index
ti
achiev
divid
cytotox
concentr
cc
noncytotox
concentr
inhibit
protect
uninfect
cell
id
report
valu
indic
extract
select
inhibit
toxic
viru
cell
co
et
al
vitro
assay
import
role
determin
antihiv
activ
mind
pitfal
fals
posit
might
aris
compound
plant
crude
extract
lack
absorpt
distribut
metabol
excret
adm
characterist
lack
direct
correl
vivoclin
dose
limit
scope
applic
vitro
bioassay
add
challeng
face
vitro
screen
agarw
et
al
often
inaccur
relat
vitro
result
enzym
protein
inhibit
assay
vivo
situat
consid
screen
botan
botan
prepar
hydrolysi
phaseii
transform
compound
within
vivo
system
contribut
incompat
vitro
result
vivo
situat
hydrolysi
flavonoid
may
result
format
nonconjug
analogu
abl
induc
specif
biolog
respons
even
larger
extent
nonhydrolys
extract
hydrolysi
also
provid
site
conjug
result
excret
conjug
urin
bile
day
et
al
type
flavonoid
posit
natur
sugar
may
also
affect
metabol
intestin
pass
larg
intestin
absorpt
barrington
et
al
hollman
aglycon
absorb
quickli
metabolis
form
phaseii
conjug
mostli
sulphat
glucuronid
omethyl
major
impact
activ
well
abil
bodi
excret
compound
barrington
et
al
hollman
phaseii
conjug
obvious
repres
compound
origin
plant
extract
botan
prepar
anymor
challeng
result
obtain
vitro
assay
wellknown
flavonoid
kaempferol
apigenin
galangin
present
low
concentr
plasma
nearli
exclus
present
conjug
glucuronid
system
circul
phaseii
biotransform
barrington
et
al
chen
et
al
hollman
quercetin
often
report
antivir
assay
known
specif
absorpt
hydrolysi
pattern
quercetin
glucosid
absorb
small
intestin
wherea
quercetin
rutinosid
absorb
colon
deglycosyl
hollman
caffeic
acid
ferul
acid
also
wellknown
antivir
compound
exampl
compound
subject
transform
metabolis
glucuronid
although
effect
spencer
et
al
glucuronid
howev
observ
chlorogen
acid
anthocyanidin
glycosid
rapidli
absorb
abl
withstand
deglycosyl
reaction
human
hollman
therefor
import
consid
factor
transform
conjug
compound
intestin
transform
compound
absorpt
transform
liver
human
bodi
affect
extrapol
vitro
result
vivo
situat
adm
characterist
mani
compound
avail
therefor
vitro
assay
base
enzym
cell
base
assay
protein
target
use
screen
aim
link
tradit
use
plant
activ
vitro
vivo
extrapol
howev
complex
inform
need
determin
vivo
situat
compound
botan
prepar
numer
compound
possibl
activ
compon
number
medicin
plant
report
antihiv
properti
chinsembu
hedimbi
co
et
al
singh
et
al
structur
divers
adapt
abil
variou
environment
condit
result
develop
rang
defens
compound
variou
biolog
activ
therefor
plant
secondari
metabolit
repres
huge
sourc
novel
antihiv
drug
may
function
hiv
guid
fraction
crude
extract
provid
platform
discoveri
novel
known
antihiv
compound
emerg
drug
resist
hiv
variant
patient
receiv
arv
treatment
search
novel
effect
inhibitor
hiv
acceler
condens
summari
activ
studi
class
plant
compound
provid
tabl
known
compound
antihiv
activ
includ
chloroquin
genistein
strictinin
chloroquin
rang
antivir
effect
vari
endocytosi
exocytosi
viral
particl
addit
regul
ifng
tnfa
product
tnfreceptor
shown
activ
sar
coronaviru
human
coronaviru
ebov
infect
vivo
newborn
mice
de
clercq
strictinin
green
tea
catechin
activ
influenza
viru
herp
simplex
hivrt
saha
et
al
genistein
inhibit
arenavir
hemorrhag
fever
infect
vitro
vela
et
al
citru
limon
lemon
lackmansmith
et
al
psidium
guajava
guava
mao
et
al
ricinu
communi
castor
oil
bessong
et
al
zingib
officinali
ginger
feng
et
al
mangifera
indica
mango
coco
nucifera
coconut
exampl
commonli
use
food
plant
proven
antivir
activ
often
specif
genu
identifi
activ
microorgan
amaryllidacea
known
alkaloid
compound
mani
identifi
antivir
activ
major
group
secondari
metabolit
occur
amaryllidacea
isoquinolin
alkaloid
variou
structur
variat
nair
van
staden
lycorin
narciclasin
pretazettin
well
known
compound
isol
famili
narciclasin
inhibit
protein
synthesi
step
peptid
bond
format
wherea
pretazettin
strongli
inhibit
activ
rnadepend
dna
polymeras
rt
variou
oncogen
virus
bind
enzym
fennel
van
staden
import
compound
known
treat
ailment
famili
includ
crinin
galanthamin
central
nervou
system
activ
due
resembl
morphin
codein
skeleton
fennel
van
staden
studi
specif
famili
amaryllidacea
might
also
yield
novel
mechan
compound
treatment
hiv
direct
research
focu
search
antivir
agent
medicin
plant
proven
antihiv
properti
usual
medicin
valu
may
indic
use
new
drug
viru
commonli
associ
infect
asr
et
al
tabl
provid
summari
plant
investig
southern
africa
present
compound
isol
activ
possibl
mode
action
compound
indic
specif
use
medicin
plant
treat
hiv
distribut
speci
present
tradit
use
speci
therefor
reflect
distribut
speci
strongli
link
avail
speci
region
plant
speci
exclud
group
helichrysum
speci
document
studi
report
popular
use
treat
hiv
hiv
symptom
report
treatment
infecti
diseas
anoth
antivir
activ
influenza
chicken
pox
wherea
mode
action
scientif
report
plant
plant
test
antihiv
activ
base
similar
plant
popular
test
antihiv
antivir
activ
elaeodendron
croceum
e
transvaalensi
e
schlechterianum
popular
use
hiv
infecti
diseas
leonoti
leonuru
l
nepetifolia
popular
use
hiv
speci
similar
commonli
use
hiv
includ
ethnobotan
document
often
incomplet
speci
often
misidentifi
activ
relat
speci
might
therefor
speci
also
commonli
use
treat
hiv
viral
infect
correctli
identifi
document
analyz
compar
inform
plant
southern
african
region
popularli
use
hiv
treatment
test
antihiv
activ
sever
compound
compound
group
repeatedli
report
evalu
compound
compound
group
classifi
three
distinct
group
three
group
identifi
flavonoid
quercetin
vernonia
amygdilana
flavonoid
glycosid
sutherlandia
frutescen
terpenoid
terpenoid
glycosid
sericosid
combretum
moll
betulin
acid
peltophorum
africanum
includ
cardiac
glycosid
found
two
elaeodendrom
speci
e
croceum
e
schlechteranum
phenol
acid
gallic
acid
rosmarin
acid
caffeic
acid
alepidea
amatymbica
conjug
acid
dicaffeoylquin
acid
dqca
vernonia
amygdilana
diand
tricaffeoylquin
acid
tcqa
variou
helichrysum
speci
trigalloylquin
acid
tgqa
myrothamnu
flabellifoliu
securidaca
longipedunculata
suffici
evid
antivir
activ
phenol
acid
accumul
year
still
explor
mani
medicin
plant
speci
heyman
et
al
dicaffeoylquin
acid
dcqa
dicaffeoyltartar
acid
dcta
select
inhibitor
concentr
nm
compound
report
date
includ
well
relat
dicaffeoyltartar
acid
lchicor
acid
mcdougal
et
al
caffeoyland
galloylquin
acid
nonspecif
antihiv
activ
bind
protein
inhibit
viru
replic
prevent
bind
receptor
also
specif
hi
viru
similar
antivir
activ
also
observ
hsv
type
galloyl
deriv
previous
shown
inhibit
vitro
activ
hivrt
cellular
dna
polymeras
particular
dna
polymeras
mahmood
et
al
mcdougal
et
al
howev
strongli
argu
activ
compound
link
hivrt
sever
time
activ
hiv
enzym
caffeoylquin
acid
show
activ
caffeic
acid
chlorogen
acid
activ
show
select
natur
wide
varieti
relat
compound
chlorogen
acid
quinic
acid
activ
reduc
amount
hbvdna
effect
viral
antigen
wang
et
al
also
show
potenti
use
cqa
treat
viral
infect
cqa
report
numer
studi
potent
activ
hsv
well
khan
et
al
lall
et
al
meyer
et
al
thompson
furthermor
shown
activ
abund
antihiv
compound
acid
tabl
inventori
plant
southern
african
region
antihiv
activ
present
distribut
tradit
use
assay
result
assay
obtain
plant
tetrazolium
base
colorimetr
assay
use
strain
iii
b
strain
rod
azt
posit
control
hoslunddiol
euscaph
acid
rt
activ
maregesi
et
al
maregesi
et
al
mujovo
et
al
prakash
staden
leav
extract
gail
et
al
ncube
et
al
viol
et
al
hypoxi
sobolifera
jacq
tradit
use
treat
infecti
diseas
hiv
tetrazolium
base
colorimetr
assay
use
strain
iii
b
strain
rod
azt
posit
control
ethanol
extract
cytotox
si
co
et
al
lamord
et
al
maregesi
et
al
maregesi
et
al
continu
next
page
g
prinsloo
et
al
journal
ethnopharmacolog
tetrazolium
base
colorimetr
assay
use
strain
iii
b
strain
rod
azt
posit
control
acid
toxic
brine
shrimp
anacard
acid
ginkgoic
acid
cytotox
compon
maregesi
et
al
maregesi
et
al
leav
rt
assay
isol
compound
addit
evalu
contain
flavonoid
cgalloylglycosid
name
catechin
bergenin
betulin
acid
pr
assay
acetyl
pepstatin
ap
use
posit
control
variou
compound
isol
includ
betulin
acid
caffeic
acid
diterpen
forskolin
pr
activ
could
attribut
diterpenoid
pr
alasbahi
melzig
chinsembu
hedimbi
kapewangolo
et
al
kim
et
al
rt
assay
doxorubicin
posit
control
gail
et
al
kadu
et
al
rukunga
et
al
rhu
chirindensi
baker
f
fresen
asr
et
al
mahmood
et
al
muazu
kaita
viol
et
al
wound
dress
rheumat
syphili
canavanin
inhibitor
nitric
oxid
synthas
potenti
treatment
septic
shock
condit
associ
advanc
stage
aid
leav
flower
inhibit
rt
hivii
pr
activ
assay
mgml
gail
et
al
harnett
et
al
van
wyk
albrecht
elisa
kit
fluorometr
detect
hivii
pr
tannin
saponin
maregesi
et
al
maregesi
et
al
maregesi
et
al
methanol
stem
bark
extract
ic
continu
next
page
g
prinsloo
et
al
journal
ethnopharmacolog
highli
bioavail
absorb
stomach
jejunum
follow
absorpt
along
small
intestin
also
larg
intestin
farah
et
al
compound
present
plasma
low
concentr
caffeic
ferul
isoferul
pcoumar
acid
farah
et
al
might
realist
record
vitro
assay
often
report
much
higher
concentr
chlorogen
acid
dihydroxycinamm
acid
caffeic
acid
describ
previous
antioxid
therefor
benefici
compound
possibl
explan
howev
prooxid
activ
oxid
form
quinon
oxid
peroxidaseh
tyrosinaseo
quinon
toxic
cell
due
creat
oxid
stress
kept
unoxidis
state
antioxid
glutathion
ascorb
acid
moridani
et
al
flavonoid
act
prooxid
produc
quinon
produc
reactiv
oxygen
speci
ro
effect
defens
herbivor
pathogen
attack
addit
caffeic
acid
mice
result
significantli
increas
level
glutathion
stransferas
gst
probabl
due
prooxid
activ
electrophilerespons
element
epr
activ
similarli
mani
cinnam
acid
shown
potent
induc
nad
p
h
quinoneacceptor
oxidoreductas
clifford
dcqa
dcta
biscatechol
appear
inhibit
rt
within
cell
act
directli
inhibit
mcdougal
et
al
mechan
phenol
acid
act
virus
inhibit
replic
infect
howev
well
research
compound
relat
chlorogen
acid
test
numer
confirm
antihiv
activ
also
activ
chiang
et
al
mcdougal
et
al
tamura
et
al
thompson
wang
et
al
also
support
tradit
popular
use
mani
plant
viral
infect
show
potent
antihiv
activ
test
vitro
poor
nutrit
inaccess
health
system
overburden
health
budget
resourc
contribut
spread
inadequ
control
continu
infect
hiv
coovadia
et
al
mani
studi
reli
tradit
use
medicin
plant
treat
viral
infect
variou
account
activ
plant
document
bessong
et
al
antihiv
activ
could
link
isol
compound
southern
african
plant
often
compound
previous
identifi
antihiv
activ
plant
region
world
therefor
evid
similar
compound
compound
group
identifi
activ
principl
plant
prepar
variou
region
world
repeat
identif
support
progress
vivo
studi
especi
southern
african
region
afford
safe
medicin
need
urgent
plant
continu
provid
drug
lead
numer
plant
andor
plant
compound
advanc
clinic
trial
yang
et
al
enough
evid
accumul
variou
studi
warrant
investig
activ
principl
chemic
profil
antivir
plant
specif
focu
three
mention
group
systemat
review
liu
yang
assess
benefici
effect
risk
herbal
medicin
patient
hiv
infect
aid
conclud
inadequ
evid
support
use
herbal
medicin
hivinfect
individu
aid
patient
howev
potenti
benefici
effect
need
confirm
larg
rigor
trial
liu
et
al
southern
african
plant
plant
compound
current
clinic
trial
studi
exampl
frutescen
indigen
lesotho
south
africa
southern
namibia
southeastern
botswana
wealth
preclin
data
van
wyk
albrecht
phase
studi
shown
rddp
bessong
et
al
ic
water
methanol
rt
ic
water
methanol
frutescen
well
toler
show
signific
side
effect
johnson
et
al
recent
result
adapt
twostag
random
doubleblind
placebo
control
studi
publish
studi
evalu
safeti
consum
dri
frutescen
hiv
seroposit
adult
tlymphocyt
count
sutherlandia
frutescen
chang
hiv
viral
load
tlymphocyt
count
similar
two
arm
week
howev
mean
total
burden
infect
greater
frutescen
arm
attribut
two
tuberculosi
case
subject
take
isoniazid
prevent
therapi
ipt
studi
conclud
possibl
interact
frutescen
ipt
need
evalu
although
safeti
issu
relat
consumpt
frutescen
identifi
wilson
et
al
equal
good
activ
compound
chlorogen
acid
virus
hsv
also
support
intensifi
vivo
studi
support
develop
plant
extract
compound
antivir
treatment
apart
frutescen
enter
clinic
studi
plant
region
advanc
stage
even
though
major
hiv
infect
individu
treat
medicin
plant
prepar
region
low
number
plant
extract
compound
advanc
studi
support
need
focu
develop
research
potenti
identifi
publish
studi
reach
commerci
market
evalu
advanc
herbal
prepar
compound
test
vivo
ensur
treatment
reach
commerci
market
throughout
paper
evid
present
show
although
southern
africa
possess
wealth
medicin
plant
research
screen
isol
activ
compound
carri
vitro
enzym
viral
protein
followup
research
valid
result
vivo
could
attribut
lack
long
term
fund
infrastructur
support
mani
plant
test
facil
within
southern
african
region
screen
literatur
would
therefor
seem
common
compound
compound
group
southern
african
plant
mani
wellknown
previous
confirm
antivir
activ
plant
area
world
repeatedli
identifi
antihiv
agent
therefor
argu
presenc
wellknown
wellresearch
plant
compound
antihiv
activ
southern
africa
direct
futur
focu
develop
antivir
agent
rapid
develop
afford
antihiv
treatment
also
followedup
vivo
studi
inform
lack
antihiv
activ
depend
vitro
assay
result
current
avail
review
current
inform
southern
african
plant
tradit
use
viral
infect
specif
hiv
treatment
hiv
relat
diseas
symptom
present
aim
develop
treatment
peopl
live
hivaid
urgent
need
fast
track
vivo
test
hivaid
clinic
trial
candid
drug
develop
compound
isol
plant
effect
afford
altern
current
treatment
option
gerhard
prinsloo
origin
work
led
discuss
topic
manag
progress
manuscript
cynthia
marokan
postgradu
student
contribut
significantli
collat
inform
discuss
manuscript
street
extens
experi
medicin
plant
research
extens
background
hiv
part
hiv
unit
mrc
contribut
significantli
content
paper
also
respons
final
edit
proof
read
paper
